首页> 外文期刊>Chemico-biological interactions >Beneficial effect of succinic acid monoethyl ester on erythrocyte membrane bound enzymes and antioxidant status in streptozotocin-nicotinamide induced type 2 diabetes.
【24h】

Beneficial effect of succinic acid monoethyl ester on erythrocyte membrane bound enzymes and antioxidant status in streptozotocin-nicotinamide induced type 2 diabetes.

机译:在链脲佐菌素-烟酰胺诱导的2型糖尿病中,琥珀酸单乙酯对红细胞膜结合酶和抗氧化剂状态的有益作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Succinic acid monoethyl ester (EMS) was recently proposed as an insulinotropic agent for the treatment of non-insulin dependent diabetes mellitus. In the present study the effect of EMS and metformin on erythrocyte membrane bound enzymes and antioxidants activity in plasma and erythrocytes of streptozotocin-nicotinamide induced type 2 diabeteic model was investigated. Succinic acid monoethyl ester was administered intraperitonially for 30 days to control and diabetic rats. The effect of EMS on glucose, insulin, hemoglobin, glycosylated hemoglobin, TBARS, hydroperoxide, superoxide dismutase (SOD), catalase (CAT), glutathione peroxide (Gpx), glutathione-S-transferase (GST), vitamins C and E, reduced glutathione (GSH) and membrane bound enzymes were studied. The effect of EMS was compared with metformin, a reference drug. The levels of glucose, glycosylated hemoglobin, TBARS, hyderoperoxide, and vitamin E were increased significantly whereas the level of insulin and hemoglobin, as well as antioxidants (SOD, CAT, Gpx, GST, vitamin C and GSH) membrane bound total ATPase, Na(+)/K(+)-ATPase, Ca(2+)-ATPase and Mg(2+)-ATPase were decreased significantly in streptozotocin-nicotinamide diabetic rats. Administration of EMS to diabetic rats showed a decrease in the levels of glucose, glycosylated hemoglobin, lipid peroxidation markers and vitamin E. In addition the levels of insulin, hemoglobin, enzymic antioxidants, vitamin C, and GSH and the activities of membrane bound enzymes also were increased in EMS and metformin treated diabetic rats. The present study indicates that the EMS possesses a significant beneficial effect on erythrocyte membrane bound enzymes and antioxidants defense system in addition to its antidiabetic effect.
机译:琥珀酸单乙酯(EMS)最近被提议作为促胰岛素治疗剂,用于治疗非胰岛素依赖型糖尿病。在本研究中,研究了EMS和二甲双胍对链脲佐菌素-烟酰胺诱导的2型糖尿病模型血浆和红细胞中红细胞膜结合酶和抗氧化剂活性的影响。腹膜内给予琥珀酸单乙酯30天,以用于对照组和糖尿病大鼠。 EMS对葡萄糖,胰岛素,血红蛋白,糖基化血红蛋白,TBARS,氢过氧化物,超氧化物歧化酶(SOD),过氧化氢酶(CAT),谷胱甘肽过氧化物(Gpx),谷胱甘肽S-转移酶(GST),维生素C和E的影响降低谷胱甘肽(GSH)和膜结合酶进行了研究。将EMS的效果与参考药物二甲双胍进行了比较。葡萄糖,糖基化血红蛋白,TBARS,过氧化氢和维生素E的水平显着增加,而胰岛素和血红蛋白以及抗氧化剂(SOD,CAT,Gpx,GST,维生素C和GSH)的膜结合总ATPase,Na (+)/ K(+)-ATPase,Ca(2 +)-ATPase和Mg(2 +)-ATPase在链脲佐菌素-烟酰胺糖尿病大鼠中显着降低。对糖尿病大鼠的EMS给药显示葡萄糖,糖基化血红蛋白,脂质过氧化标记和维生素E的水平降低。此外,胰岛素,血红蛋白,酶促抗氧化剂,维生素C和GSH的水平以及膜结合酶的活性也降低了。在EMS和二甲双胍治疗的糖尿病大鼠中,它们的表达增加。本研究表明,EMS除具有抗糖尿病作用外,还对红细胞膜结合酶和抗氧化剂防御系统具有显着的有益作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号